Microbot Medical Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.93, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Microbot Medical Inc in Jun 30 2026 quarter, has decreased to 74 days, compared to 91 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Microbot Medical Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Microbot Medical Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MBOT Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	4.93	4	-	-	-
MBOT's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	74	91	-	-	-
Seq. Receivable Change	67.62 %	-	-	-	-
Seq. Revenue Change	129.52 %	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

MBOT Company Profile • Back to MBOT Efficiency Comparisons • Compare MBOT Receivables Turnover Ratio to its Competitors

Financial Statements
Microbot Medical Inc 's Accounts Receivable	$ 0 Millions	Visit MBOT's Balance sheet
Microbot Medical Inc 's Sales TTM	$ 0 Millions	Visit MBOT's Income Statement
Sources of MBOT's Revenues		Visit MBOT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MBOT's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MBOT's Growth Rates	MBOT's Roa	MBOT's Inventory Turnover Ratio	MBOT's Dividend Comparisons
MBOT's Profitability Ratios	MBOT's Roi	MBOT's Asset Turnover Ratio	MBOT's Dividend Growth
MBOT's Valuation Ratios	MBOT's Roe	MBOT's Financial Strength Ratios	MBOT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Sintx Technologies Inc	5.37	$ 1.330 Millions	$ 0.248 Millions
Igc Pharma Inc	5.36	$ 1.101 Millions	$ 0.206 Millions
Cytokinetics Incorporated	5.33	$ 67.670 Millions	$ 12.708 Millions
Strata Critical Medical Inc	5.27	$ 211.642 Millions	$ 40.126 Millions
Karyopharm Therapeutics Inc	5.27	$ 146.621 Millions	$ 27.821 Millions
Enovis Corp	5.21	$ 2,294.938 Millions	$ 440.151 Millions
The Cooper Companies Inc	5.20	$ 4,236.600 Millions	$ 814.025 Millions
Cryoport inc	5.19	$ 186.452 Millions	$ 35.933 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
Pluri Inc	5.15	$ 1.016 Millions	$ 0.197 Millions
Opus Genetics Inc	5.13	$ 9.856 Millions	$ 1.921 Millions
Carlsmed Inc	5.13	$ 62.457 Millions	$ 12.175 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pacific Biosciences Of California Inc	5.04	$ 159.315 Millions	$ 31.630 Millions
Sarepta Therapeutics Inc	5.03	$ 1,974.344 Millions	$ 392.275 Millions
Amphastar Pharmaceuticals Inc	5.01	$ 730.019 Millions	$ 145.768 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Stereotaxis Inc	4.98	$ 29.892 Millions	$ 6.008 Millions
Invivyd Inc	4.96	$ 58.365 Millions	$ 11.776 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Cytosorbents Corporation	4.93	$ 35.663 Millions	$ 7.229 Millions
Plus Therapeutics Inc	4.90	$ 4.203 Millions	$ 0.858 Millions
Mirum Pharmaceuticals Inc	4.86	$ 618.067 Millions	$ 127.234 Millions
Ultragenyx Pharmaceutical Inc	4.85	$ 717.212 Millions	$ 147.886 Millions
Abeona Therapeutics Inc	4.83	$ 30.093 Millions	$ 6.232 Millions
Xtant Medical Holdings Inc	4.81	$ 108.748 Millions	$ 22.594 Millions
Ligand Pharmaceuticals Incorporated	4.77	$ 290.542 Millions	$ 60.966 Millions
Elanco Animal Health Incorporated	4.76	$ 5,020.000 Millions	$ 1,055.250 Millions

Date modified: 2026-09-08T18:50:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.